Innovation Pharmaceuticals Inc (IPIX)

[stocksbelow1]

"And nothing substantial ever materializes. Ehrlich - huge on hype little on delivery".


Many of us that have an investment in IP actually think that getting B for C to a clinical trial is pretty substantial. Whether or not it shows efficacy is in B's (Brilacidin) hands now. AND, based on previous RBL's tests in vitro, and in vero, with a selectivity index of 426 vs Remdesivir's 126 we are hopeful for a good outcome, not only for our sakes as investors, but for humanity as well.

$IPIX$